Natsar Pharmaceuticals, Inc.
Pharmaceutical company · Ellicott City, Maryland, United States
Natsar Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Ellicott City, Maryland, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.6 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $4.2 million sold in a notice filed in 2026.
Natsar Pharmaceuticals at a glance
What does Natsar Pharmaceuticals do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $1.6 million in total (2025). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $4.2 million sold (2026).
Frequently asked questions about Natsar Pharmaceuticals
Where is Natsar Pharmaceuticals headquartered?
Natsar Pharmaceuticals, Inc. is headquartered in Ellicott City, Maryland, United States.
What does Natsar Pharmaceuticals do?
Natsar Pharmaceuticals, Inc. is a pharmaceutical company.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences